AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JAN 16 - (NewsRx.com & NewsRx.net) -- BioForce Nanosciences, Inc., said that a Department of Defense grant for breast cancer research has been awarded to the company.
The award titled, "Protein Nanoarrays for Studying Malignant Progression in Breast Cancer Cell Lines," aims to construct a nano-scale protein array platform and use it as a basic research tool to study alterations in cellular signaling pathways that accompany breast cancer disease progression.
The nanoarray technology is being optimized for various biological applications, particularly cancer research. Principal investigator Janice Huff, PhD, states that, "BioForce's nanoarray format provides a realistic platform for performance of array-based analyses in applications involving extremely small quantities of sample material where use of current microarray formats are not feasible."
BioForce's proprietary, ultraminiaturized nanoarrays permit a vast reduction in the amount of materials necessary for analysis. Molecules are placed on solid surfaces at defined locations in the micron and submicron spatial ...
Source: HighBeam Research, Nanoarray biomolecular analysis systems maker receives DoD...